Mitral Regurgitation Clinical Trial
Official title:
Patient Specific Mitral Valve Modeling for Surgical Planning and Training
Mitral valve disease is a common pathologic problem occurring in approximately 2% of the
general population but climbing to 10% in those over the age of 75 in Canada[1]. This project
has three primary goals all of which will positively affect cardiac patient care.
1) Create patient specific MV models for complex repairs that will allow surgeons the
opportunity to practice the repair. 2) Potentially predict the outcomes following minimally
invasive repair techniques such as transcatheter treatments (e.g., MitraClip). 3) Provide a
model to train individuals on mitral valve repair techniques.
BACKGROUND Mitral valve disease is a common pathologic problem occurring in approximately 2%
of the general population, but climbing to 10% in those over the age of 75 in Canada. Of this
group, approximately 20% have a sufficiently severe form of the disease that may require
surgical intervention to restore normal valve function and prevent early mortality [4].
Evidence indicates that the surgeon's individual volume of mitral valve repair cases
performed is a determinant of not only successful mitral repair rates, but also freedom from
reoperation, and patient survival. For patients previously deemed inoperable due to
co-morbidities, new techniques to treat mitral valve disease are being developed. However,
assessing the optimal approach and the point at which clinical benefit is exceeded by the
poor value or futility of the procedure is one of the biggest clinical challenges for
physicians.
In the past decade, 3D echocardiography has emerged as a standard of care in diagnostic and
interventional imaging for cardiac surgery and cardiology. This, coupled with the emergence
of inexpensive 3D printing technology has led researchers and clinicians to explore how
improved imaging and additive manufacturing can be used to improve patient outcomes.
In this context, the investigators have completed a proof-of-concept workflow for creating
dynamic, patient specific mitral valve models. In concert with a left ventricle simulator 8],
these valve models can mimic patient valve pathologies both anatomically and dynamically, as
shown in Doppler ultrasound. In a 10 patient retrospective study, the investigators have
demonstrated the ability to accurately re-create patient pathology, perform realistic
surgical repairs, and assess realistic valve function post repair. The study team's vision is
to create a simulator that can be used to assess patient candidacy for percutaneous
interventions, assess different repair options for both percutaneous and surgical
interventions, and finally use the model as a simulator for competency-based MV
interventions.
RATIONALE Based on our successful proof of concept, the goal is to translate this technology
to clinical use by validating our valve models. There are two primary long term goals. First,
to validate a system for using patient specific MV models to: 1- assess intervention options,
and 2: plan repair strategies for improved patient outcomes. Second, by building a database
of MV pathologies, create a competency based simulator/trainer to provide surgeons with
increased experience in MV repair techniques.
OBJECTIVES
1. Validate the accuracy of patient specific MV pathologies and repairs in a prospective 65
patient study;
2. Optimize our work-flow for creating valve models, in terms of accuracy, manufacture time
required, and expense;
3. Validate the accuracy of our patient models for both surgical cases and transcatheter
MitraClip interventions;
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03278574 -
Flexible Band vs Rigid Ring for Degenerative Mitral Valve Disease
|
N/A | |
Suspended |
NCT04960280 -
A Study to Evaluate a Computerized Stethoscope Called ©Voqx to Diagnose Heart Disease
|
N/A | |
Recruiting |
NCT05021614 -
Valveclip® Transcatheter Mitral Valve Repair Study
|
N/A | |
Not yet recruiting |
NCT06465745 -
AltaValve Pivotal Trial
|
N/A | |
Not yet recruiting |
NCT06167213 -
ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral
|
N/A | |
Withdrawn |
NCT05040451 -
Carillon Mitral Contour System for Treatment of Exercise Induced Functional Mitral Regurgitation
|
||
Withdrawn |
NCT03714412 -
Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System
|
N/A | |
Recruiting |
NCT02592889 -
(MitraClip in Non-Responders to Cardiac Resynchronization Therapy)
|
Phase 4 | |
Completed |
NCT02355418 -
The Role of Myocardial Fibrosis in Degenerative Mitral Regurgitation
|
||
Not yet recruiting |
NCT01431222 -
Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery
|
Phase 4 | |
Completed |
NCT01841554 -
Cardioband With Transfemoral Delivery System
|
N/A | |
Not yet recruiting |
NCT03870516 -
Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery
|
N/A | |
Active, not recruiting |
NCT03230747 -
SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation
|
N/A | |
Enrolling by invitation |
NCT04031274 -
Transcatheter Treatment for Combined Aortic and Mitral Valve Disease. The Aortic+Mitral TRAnsCatheter (AMTRAC) Valve Registry
|
||
Completed |
NCT05836532 -
Long Term Results of Surgical and Percutaneous Double Orefices Mitral Repair in Patient With p2 Prolapse Causing Degenerative Mitral Regurgitation
|
||
Completed |
NCT05836480 -
Immediate Suboptimal Result of Mitral Valve Repair: Late Implications in a Matched Cohort Study
|
||
Completed |
NCT05850026 -
Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way!
|
||
Recruiting |
NCT03975998 -
Dutch-AMR: Early Mitral Valve Repair Versus Watchful Waiting in Asymptomatic Patients With Severe Mitral Regurgitation
|
||
Completed |
NCT01162083 -
Identifying an Ideal Cardiopulmonary Exercise Test Parameter
|
N/A | |
Suspended |
NCT00787293 -
Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients
|
Phase 2 |